Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

379 ARTÍCULOS , VIENDO DEL 286 AL 300

Auditory hallucinations associated with nitrofurantoin use: case report and review of the literature

Štuhec M.

Wien Klin Wochenschr. 2014 Sep;126(17-18):549-52. doi: 10.1007/s00508-014-0577-6. Epub 2014 Aug 15.

Can antidepressant medication relieve agitation in Alzheimer's disease?

Porsteinsson AP, Smith JS, Keltz MA, Antonsdottir IM.

Expert Rev Neurother. 2014 Sep;14(9):969-71. doi: 10.1586/14737175.2014.947964.

[The influence of anosognosia and depression on the perceived quality of life of patients with Alzheimer's disease: a 12 months follow-up]

Portellano-Ortiz C, Turró-Garriga O, Gascón-Bayarri J, Piñán-Hernández S, Moreno-Cordón L, Viñas-Díez V, Reñé-Ramírez R, Conde-Sala JL.

Rev Neurol. 2014 Sep 1;59(5):193-204.

Biological mechanisms linking Alzheimer's disease and type-2 diabetes mellitus

Mushtaq G, Khan JA, Kamal MA.

CNS Neurol Disord Drug Targets. 2014;13(7):1192-201. doi: 10.2174/1871527313666140917114537.

Beta and gamma carboline derivatives as potential anti-Alzheimer agents: A comparison

Otto R, Penzis R, Gaube F, Winckler T, Appenroth D, Fleck C, Tränkle C, Lehmann J, Enzensperger C.

Eur J Med Chem. 2014 Nov 24;87:63-70. doi: 10.1016/j.ejmech.2014.09.048. Epub 2014 Sep 16.

Efficacy of vitamins B supplementation on mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis

Li MM, Yu JT, Wang HF, Jiang T, Wang J, Meng XF, Tan CC, Wang C, Tan L.

Curr Alzheimer Res. 2014;11(9):844-52.

General anesthetic and the risk of dementia in elderly patients: current insights

Hussain M, Berger M, Eckenhoff RG, Seitz DP.

Clin Interv Aging. 2014 Sep 24;9:1619-28. doi: 10.2147/CIA.S49680. eCollection 2014.

Role of the extended MAPT haplotype in the worsening of psychotic symptoms and treatment response in Alzheimer disease

Creese B, Corbett A, Jones E, Fox C, Ballard C.

J Am Med Dir Assoc. 2014 Dec;15(12):934-7. doi: 10.1016/j.jamda.2014.08.011. Epub 2014 Oct 11.

[Pharmacological and other options in preventing dementia: a literature review]

Csukly G, Sirály E, Hidasi Z, Salacz P, Szabó Á, Csibri É.

Neuropsychopharmacol Hung. 2014 Sep;16(3):121-6.

Initial and long-term evaluation of patients with Alzheimer's after hospitalization in cognitive and behavioural units: the EVITAL study design

Pongan E, Freulon M, Delphin-Combe F, Dibie-Racoupeau F, Martin-Gaujard G, Federico D, Waissi A, Richard G, Jacqueline S, Fabre F, Trombert-Paviot B, Krolak-Salmon P, Laurent B, Rouch I.

BMC Psychiatry. 2014 Nov 15;14:308. doi: 10.1186/s12888-014-0308-6.

[Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?]

García-Casares N, García-Arnés JA, Gómez-Huelgas R, Valdivielso-Felices P, García-Arias C, González-Santos P.

Rev Neurol. 2014 Dec 1;59(11):517-24.

Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services

Wattmo C, Londos E, Minthon L.

Clin Interv Aging. 2014 Nov 14;9:1951-62. doi: 10.2147/CIA.S71709. eCollection 2014.

Searching for disease-modifying drugs in AD: can we combine neuropsychological tools with biological markers?

Caraci F, Castellano S, Salomone S, Drago F, Bosco P, Di Nuovo S.

CNS Neurol Disord Drug Targets. 2014 Feb;13(1):173-86. doi: 10.2174/18715273113129990103.

Proteomics approaches to understand linkage between Alzheimer's disease and type 2 diabetes mellitus

Mirza Z, Ali A, Ashraf GM, Kamal MA, Abuzenadah AM, Choudhary AG, Damanhouri GA, Sheikh IA.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):213-25. doi: 10.2174/18715273113126660144.

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers

Shen L, Thompson PM, Potkin SG, Bertram L, Farrer LA, Foroud TM, Green RC, Hu X, Huentelman MJ, Kim S, Kauwe JS, Li Q, Liu E, Macciardi F, Moore JH, Munsie L, Nho K, Ramanan VK, Risacher SL, Stone DJ, Swaminathan S, Toga AW, Weiner MW, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2014 Jun;8(2):183-207. doi: 10.1007/s11682-013-9262-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias